Twice-Daily Antibiotic Regimen Boosts Therapeutic Compliance – Medscape News

March 8, 2012 — Use of twice-daily amoxicillin/clavulanic acid (Augmentin XR, GlaxoSmithKline), rather than the standard thrice-daily version (Augmentin, GlaxoSmithKline), may be the key to improving therapeutic adherence, a Spanish study suggests.

Leave a Reply

Your email address will not be published.

*